Table 4.
Treatment protocols and outcomes for patients with UVAL
| Treatment | Resolved without sequelae after treatment | Recurrence | |
|---|---|---|---|
| 1 | SA, OT | + | − |
| 2 | SS, SA | + | − |
| SA | + | − | |
| OT | + | NA | |
| SS, TA | + | NA | |
| 3 | SA | + | NA |
| 4 | SS | + | NA |
| 5 | SA | + | − |
| 6 | SA, TS | + | − |
| 7 | OT | + | − |
| 8 | NA | NA | NA |
| 9 | OT | NA | NA |
| 10 | SS, OT | + | NA |
| SA, SS | NA | − | |
| 11 | SA | + | − |
| 12 | SA | + | − |
| 13 | SH | + | − |
| SH | + | − | |
| 14 | OT | + | − |
| 15 | TA | + | − |
| TA | + | − | |
| NA | + | − | |
| 16 | TA, OT | + | − |
| 17 | SS, SA, OT | + | − |
| 18 | TS | + | + |
| 19 | SA, TA, SS | − | NA |
| 20 | SS | + | − |
| 21 | SA, OT | − | − |
|
CR/(CS): SA: n = 12 (NA) TA: n = 5 (NA) SS: n = 8 (NA) TS: n = 2 (NA) SH: n = 2 (NA) OT: n = 9 (NA) |
CR/(CS): yes: n = 23 (NA) no: n = 2 (NA) NA: n = 2 (NA) |
CR/(CS): Yes: n = 1 (NA) No: n = 19 (NA) NA n = 7 (NA) |
−, no; +, yes; NA, not available; OT, others; SA, systemic antibiotics; SH, spontaneous healing; SS, systemic steroids; TA, topical antibiotics; TS, topical steroids.